COMPOSITIONS COMPRENANT UNE CO-FORMULATION D'ANTICORPS ANTI-PD-L1 ET ANTI-CTLA-4

• 收藏
• 分享

专利权人:

LLC;MEDIMMUNE

发明人:

DU, JIALI,SHAH, AMBARISH

申请号：

CA3020893

公开号：

CA3020893A1

申请日:

2017.04.24

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

Provided herein are compositions comprising coformulation of anti-PD-Ll and anti-CTLA-4 antibodies, or antigen-binding fragments thereof, and methods of making and using such compositions. In various aspects, stable coformulations of the anti-PD-Ll antibody durvalumab (MEDI4736) and the anti-CTLA-4 antibody tremelimumab are provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/